DBV Share Price
NASDAQ: DBVT | Small Cap | HealthcareDBV Stock Performance
DBV Share Price Today
As of 22 November 2026, DBV Technologies S.A.'s share price is $9.01. The stock opened at $9.35, compared to its previous close of $9.43. During today's trading session, DBV Technologies S.A.'s share price traded between $9.01 and $9.43, with an average price of $9.22. Over the past 52 weeks, the stock has recorded a high of $26.15 and a low of $8.65. In terms of performance, DBV Technologies S.A.'s share price has declined by 52.93% over the last six months and is down 31.01% on a year-on-year basis.
DBV Share Price Chart
DBV Quarterly Profit & Loss
All figures in USD
DBV Annual Profit & Loss
All figures in USD
DBV Balance Sheet
All figures in USD Million
DBV Cash Flow
All figures in USD Million
Corporate Actions
About DBV
DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.
DBV Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $9.39 | $9.01 | -5.46% |
Oct 2026 | $11.32 | $9.53 | -19.10% |
Sep 2026 | $13.67 | $11.78 | -18.34% |
Aug 2026 | $13.22 | $14.43 | +7.09% |
Jul 2026 | $16.29 | $13.47 | -17.82% |
Jun 2026 | $18.37 | $16.39 | -14.37% |
May 2026 | $19.98 | $19.14 | -8.73% |
Apr 2026 | $21.35 | $20.97 | +0.05% |
Mar 2026 | $21.22 | $20.96 | +0.00% |
Feb 2026 | $22.14 | $20.96 | -3.08% |
Jan 2026 | $19.02 | $21.63 | +12.87% |
Dec 2025 | $13.35 | $19.16 | +46.71% |